EMBARGOED FOR RELEASE UNTIL 9 AM ET, February 21, 2013
AAN Releases List of Five Tests and Procedures You Should Question With Your Doctor
WASHINGTON -
The is releasing a list of five tests, procedures, and treatments that doctors and their patients should question as part of today鈥檚 announcement regarding the Choosing Wisely campaign by the American Board of Internal Medicine (ABIM) Foundation. in the February 21, 2013, online issue of Neurology, the medical journal of the 好色先生. Sixteen other medical societies are also releasing their lists. Choosing Wisely is an initiative endorsed by the AAN and 33 other medical specialty societies intended to spark conversations between physicians and patients about what care is appropriate for their condition, avoiding unnecessary tests and procedures. 鈥淲ith one in six people affected by a brain disease, such as headache, multiple sclerosis, and stroke, our goal is to have patients discuss our Choosing Wisely recommendations regarding medical procedures, therapies, and tests with their neurologists,鈥 said Bruce Sigsbee, MD, FAAN, President of the 好色先生, the world鈥檚 largest association of neurologists with more than 25,000 members. 鈥淎 broad range of neurologists reviewed the evidence that contributed to these recommendations, aimed at helping other neurologists and their patients make informed decisions based on a patient鈥檚 individual situation,鈥 said lead author Annette Langer-Gould, MD, PhD, with Southern California Kaiser Permanente Medical Group and a member of the 好色先生. The five recommendations are: Don鈥檛 perform electroencephalography (EEG) for headaches. Recurrent headache is the most common pain problem, affecting up to 20 percent of people. The recommendation states that EEG has no advantage over clinical evaluation in diagnosing headache, does not improve outcomes, and increases costs. Don鈥檛 perform imaging of the carotid arteries in the neck for simple fainting without other neurologic symptoms. Fainting is a frequent complaint, affecting up to 40 percent of people during their lifetime. Carotid artery disease does not cause fainting but instead causes focused neurologic problems such as weakness on one side of the body. Due to this, carotid imaging will not identify the cause of the fainting and increases cost. Don鈥檛 use opioid or butalbital treatment for migraine except as a last resort. Opioid and butalbital treatment for migraine should be avoided because more effective, migraine-specific treatments are available. Frequent use of opioid and butalbital treatment can worsen headaches. Opioids should be used only for those with medical conditions preventing the use of migraine-specific treatments or for those who fail these treatments. Don鈥檛 prescribe interferon-beta or glatiramer acetate to patients with disability from progressive, non-relapsing forms of multiple sclerosis (MS). Interferon-beta and glatiramer acetate, medications often prescribed for MS, do not prevent the development of permanent disability in progressive forms of multiple sclerosis. These medications increase costs and have frequent side effects that may negatively affect quality of life. Don鈥檛 recommend CEA for asymptomatic carotid stenosis unless the complication rate is low, or less than three percent. Several specialty societies have recommended that surgery for patients without symptoms should be reserved for those with a perioperative (from time of hospitalization for surgery to time of discharge) complication risk of less than 3 percent and a life expectancy of greater than three to five years. American Heart Association guidelines state that it is 鈥渞easonable鈥 to perform CEA for asymptomatic patients with greater than 70 percent stenosis if the surgical complication rate is 鈥渓ow.鈥 Reported complication rates vary widely by location, and are dependent on how complications are tracked. Despite calls 15 years ago for rigorous monitoring, most patients will likely need to rely on the surgeon鈥檚 self-reported rates. Find out more about Choosing Wisely and view the Academy鈥檚 full recommendations at .